BioSpace News Archive

The healthcare industry is in compelling need of excellent growth in different domains. There is a crucial requirement for effective diagnostic to cure life-threatening diseases.

According to the report, the global dental 3D printing market was valued at US$ 1.3 Bn in 2020 and is projected to expand at a CAGR of ~9% from 2021 to 2031.

The buccal drug delivery systems market is expected to experience various growth opportunities in the years to come.

Transparency Market Research has published a new report titled, ‘Global Bone Graft Substitutes Market.’ According to the report, the global bone graft substitutes market was valued at US$ 2.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030.

According to the report, the global blood thawing system market was valued at ~US$ 174 Mn in 2019.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global peak flow meter market size is projected to surpass US$ 26 Mn, exhibiting growth at over 2% CAGR during the forecast period from 2019 to 2029, predicts Fact.MR.

MedMira Inc. announced today the appointment of Mr. Thomas Bergmann to the board effective immediately.

Ipsen and GENFIT have entered into a long-term strategic partnership for global collaboration between the two companies.

GENFIT is pleased to announce the strengthening of its cholestatic disease franchise through the acquisition of exclusive rights from Genoscience Pharma to develop and commercialize the investigational treatment GNS561 in cholangiocarcinoma in the United States, Canada and Europe, including the United Kingdom and Switzerland.

Basilea Pharmaceutica Ltd. announced that the U.S. Food and Drug Administration has approved the company’s Investigational New Drug application for the novel kinase inhibitor BAL0891, a potential first-in-class mitotic checkpoint inhibitor that drives aberrant tumor cell division leading to tumor cell death.